A critical advance in cancer research is arising with the use of nanobodies to re-engage mutated p53. This vital malignant inhibitor protein is frequently disabled in many types of malignancies, leading uncontrolled https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research